The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Classic trick, trying to get some cheap sellers to surrender.
However you will see size buyers stepping back in, post 07.00AM coffee and 25 on the offer will be lifted.
Get in if you can and you will find yourself up +20% by Thursday, Friday you will lucky to get a price below 40!
Watch how NY will begin to look closer at the reason behind the latest research’s author’s enthusiasm for AVA3996 as well , having est. almost $1 bill in peak revenue for AVA6000!! Cannot wait for further est. for the rest of the AVA family!
Why would Avacta have another Investor meet company at the upcoming numbers unless they had something to tell us!!
Hottest biotech IPO this autumn!
Watch the size buyers stepping in and it is only Thursday, been a short week.
Coronavirus testing and monitoring are set to be scaled up for the winter, the UK’s public health agency has said, as pressures on the health service are expected to rise in the coming months.
Scientists warned last month that the UK was nearly “flying blind” when it comes to Covid, because many of the surveillance programmes that were in place at the height of the pandemic have been wound down.
You must understand that this stock is no longer for day trading !
Patience and being able to afford holding on and picking up more stock on quiet days and you will find you will look very clever by the end of September.
The trick is not to sell too early.
Size buyer stepping in.
Lively week ahead, latest company presentation talks of spinning off The diagnostic business, which with the upcoming AVA news flow, will only highlight the real value of the therapeutic business , if an IPO should be on the cards, before we have somebody else knocking on the door.